Wolverine Trading
ELV icon

Wolverine Trading’s Elevance Health ELV Stock Holding History

Wolverine Trading’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,997
Closed -$3.89M – 4968
2025
Q1 		$3.89M Sell
8,997
-2,364
-21% -$949K ﹤0.01% 1132
2024
Q4 		$4.19M Buy
11,361
+10,803
+1,936% +$4.52M ﹤0.01% 1341
2024
Q3 		$292K Buy
+558
New +$298K ﹤0.01% 3658
2024
Q1 		– Sell
-2,754
Closed -$1.37M – 4697
2023
Q4 		$1.3M Buy
+2,754
New +$1.27M ﹤0.01% 2048
2023
Q3 		– Sell
-2,187
Closed -$992K – 4644
2023
Q2 		$962K Buy
2,187
+663
+44% +$306K ﹤0.01% 2035
2023
Q1 		$699K Sell
1,524
-1,145
-43% -$545K ﹤0.01% 2212
2022
Q4 		$1.37M Buy
2,669
+879
+49% +$446K ﹤0.01% 1627
2022
Q3 		$818K Buy
1,790
+817
+84% +$391K ﹤0.01% 2142
2022
Q2 		$472K Buy
+973
New +$481K ﹤0.01% 2600
2021
Q2 		– Sell
-6,704
Closed -$2.44M – 6181
2021
Q1 		$2.44M Sell
6,704
-9,288
-58% -$2.99M ﹤0.01% 1737
2020
Q4 		$5.02M Buy
15,992
+12,638
+377% +$3.88M 0.01% 1052
2020
Q3 		$871K Sell
3,354
-701
-17% -$189K ﹤0.01% 2209
2020
Q2 		$1.05M Sell
4,055
-4,471
-52% -$1.19M ﹤0.01% 1958
2020
Q1 		$1.97M Sell
8,526
-24,991
-75% -$6.81M 0.01% 1354
2019
Q4 		$10.2M Sell
33,517
-7,591
-18% -$2.09M 0.03% 662
2019
Q3 		$9.77M Buy
41,108
+4,250
+12% +$1.16M 0.03% 532
2019
Q2 		$10.4M Buy
36,858
+36,152
+5,121% +$9.88M 0.03% 515
2019
Q1 		$203K Buy
+706
New +$204K ﹤0.01% 3804
2017
Q2 		– Sell
-3,751
Closed -$674K – 4407
2017
Q1 		$627K Sell
3,751
-14,110
-79% -$2.24M ﹤0.01% 2148
2016
Q4 		$2.57M Sell
17,861
-9,552
-35% -$1.28M 0.01% 1159
2016
Q3 		$3.42M Buy
+27,413
New +$3.54M 0.02% 954

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Wolverine Trading's ELV Position: Q2 2025 in Review

Wolverine Trading sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 8,997 shares — an estimated $3.89M sold.

Wolverine Trading first reported a position in ELV in Q3 2016 and held it in 21 quarters. The position peaked at $10.4M in Q2 2019. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Wolverine Trading reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Wolverine Trading sold 8,997 Elevance Health shares in Q2 2025, an estimated $3.89M.
  • Wolverine Trading first reported a position in Elevance Health in Q3 2016 and held it in 21 quarters.
  • Wolverine Trading's Elevance Health position peaked at $10.4M in Q2 2019.
  • 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.